Global Urinary Tract Infection therapeutics Market

A urinary tract infection (UTI) is considered as one of the most common types of infection and is caused by microbes such as bacteria overcoming the bodys defenses in the urinary tract. The urinary tract can be divided into the upper urinary tract consisting of kidneys and the ureters and the lower urinary tract that consists of the bladder and the urethra. The common symptoms include a frequent and strong urge to urinate along with a painful and burning sensation when urinating, strong odour of the urine and cloudy or blood-tinged urine.

Market Dynamics

UTI result in around 8.1 million visits to a doctor every year. This high prevalence rate is a strong cause for R&D in the field and hence the market has great potential. The market is further set to increase with the sudden rise in the prevalence rate and the diagnosis of the disease. This has set to motion The Opportunities for Key players to implement their resources towards research and development of a combination therapy. This will surely increase the market size during the forecasting period. With the launch of new drugs for multiple indications under UTIs and label expansion for already existing drugs, the market is set to boost further.

Market Segmentation

The market for UTI can be segmented based on their type, distribution channel, and geography. In terms of types of drugs, the market has been categorized into quinolones, penicillin & combinations, cephalosporin, azoles & amphotericin B, sulphonamides, aminoglycoside-antibodies, nitrofurans, and tetracycline. Further on the basis of distribution channel, the urinary tract infection therapeutics market has been segmented into retail pharmacies, hospital pharmacies, and e-commerce. The hospital pharmacies and the retail pharmacies segments hold the major share of the market.

Regional/Geographic Analysis

The global urinary tract infection therapeutics market has been segmented in terms of region as follows- North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds the largest share of the global urinary tract infection therapeutics market due to high health care awareness, high diagnostic rate, and high prevalence of disease such as diabetes in the region. Europe accounted for the second largest share of the market due to rising research and development. However, Asian countries are expected to be the fastest growing markets due to increasing personal care and hygiene, growing awareness, rising rate of diagnostics, gradual adoption of improved technologies, emerging healthcare infrastructures, and increased disposable income. Another factor which will uplift the demand for urinary tract infection therapeutics is increasing geriatric population as the population is at high risk of the infection.

Key players

Some of the major players in the urinary tract infection therapeutics market include Pfizer, Inc., AstraZeneca plc, Novartis International AG., F. Hoffmann La Roche Ltd., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, BoehringerIngelheim GmbH, and CiplaLtd.

Report Contents:

> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key players

Regional Analysis:

> North America

>> US and Canada


> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America


> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe


> Eastern Europe

>> Russia
>> Poland
>> Rest of Eastern Europe


> Asia Pacific

>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific


> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa



This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on Market Segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market Dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage

Global AI in Healthcare Market Report 2019 - Market Size, Share, Price, Trend and Forecast

The global market size of AI in Healthcare is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the

USD 4000 View Report

Global Yersinia Diagnostics Market, 2019-2023: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--US, Europe, Japan--Hospitals, Commercial and Public Health Labs, POC Locations

The report presents a detailed analysis of the Yersinia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Yersinia definition,

USD 4350 View Report

Asia Pacific Hospital Acquired Urinary Tract Infection Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Hospital Acquired Urinary Tract Infection market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX

USD 3000 View Report

Europe Hospital Acquired Urinary Tract Infection Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Europe Hospital Acquired Urinary Tract Infection market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available